Advertisement

Index by author

February 01, 2004; Volume 65,Issue 2

A

  1. Adams, B. A.

    1. Differential Modulation of CaV2.3 Ca2+ Channels by Gαq/11-Coupled Muscarinic Receptors
      R. A. Bannister, K. Melliti and B. A. Adams
      Molecular Pharmacology February 2004, 65 (2) 381-388; DOI: https://doi.org/10.1124/mol.65.2.381

  2. Adegboyega, Patrick A.

    1. Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts
      Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega and Don W. Powell
      Molecular Pharmacology February 2004, 65 (2) 470-478; DOI: https://doi.org/10.1124/mol.65.2.470

B

  1. Backlund, Maria

    1. Different Structural Requirements of the Ligand Binding Domain of the Aryl Hydrocarbon Receptor for High- and Low-Affinity Ligand Binding and Receptor Activation
      Maria Backlund and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 2004, 65 (2) 416-425; DOI: https://doi.org/10.1124/mol.65.2.416

  2. Baker, Elizabeth R.

    1. Pharmacological Properties of α9α10 Nicotinic Acetylcholine Receptors Revealed by Heterologous Expression of Subunit Chimeras
      Elizabeth R. Baker, Ruud Zwart, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology February 2004, 65 (2) 453-460; DOI: https://doi.org/10.1124/mol.65.2.453

  3. Bannister, R. A.

    1. Differential Modulation of CaV2.3 Ca2+ Channels by Gαq/11-Coupled Muscarinic Receptors
      R. A. Bannister, K. Melliti and B. A. Adams
      Molecular Pharmacology February 2004, 65 (2) 381-388; DOI: https://doi.org/10.1124/mol.65.2.381

  4. Bayer, Barbara

    1. Systemic Morphine Administration Suppresses Genes Involved in Antigen Presentation
      Karen Beagles, Anton Wellstein and Barbara Bayer
      Molecular Pharmacology February 2004, 65 (2) 437-442; DOI: https://doi.org/10.1124/mol.65.2.437

  5. Beagles, Karen

    1. Systemic Morphine Administration Suppresses Genes Involved in Antigen Presentation
      Karen Beagles, Anton Wellstein and Barbara Bayer
      Molecular Pharmacology February 2004, 65 (2) 437-442; DOI: https://doi.org/10.1124/mol.65.2.437

  6. Becker, Bryan N.

    1. The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties
      Bryan N. Becker, Hui-fang Cheng, Timothy G. Hammond and Raymond C. Harris
      Molecular Pharmacology February 2004, 65 (2) 362-369; DOI: https://doi.org/10.1124/mol.65.2.362

  7. Blumberg, Peter M.

    1. Design of a High-Affinity Competitive Antagonist of the Vanilloid Receptor Selective for the Calcium Entry-Linked Receptor Population
      Attila Tóth, Peter M. Blumberg, Zili Chen and Alan P. Kozikowski
      Molecular Pharmacology February 2004, 65 (2) 282-291; DOI: https://doi.org/10.1124/mol.65.2.282

  8. Bright, Damian P.

    1. Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
      Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
      Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443

  9. Brinckerhoff, Constance E.

    1. Peroxisome Proliferator-Activated Receptor-γ-Independent Repression of Collagenase Gene Expression by 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Prostaglandin 15-Deoxy-Δ(12,14) J2: A Role for Smad Signaling
      Kimberlee S. Mix, Charles I. Coon, Evan D. Rosen, Nanjoo Suh, Michael B. Sporn and Constance E. Brinckerhoff
      Molecular Pharmacology February 2004, 65 (2) 309-318; DOI: https://doi.org/10.1124/mol.65.2.309

  10. Bushell, Trevor J.

    1. Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
      Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
      Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443

C

  1. Chan, Julie Y. H.

    1. Nitric Oxide Regulates c-fos Expression in Nucleus Tractus Solitarii Induced by Baroreceptor Activation via cGMP-Dependent Protein Kinase and cAMP Response Element-Binding Protein Phosphorylation
      Samuel H. H. Chan, Kui-Fen Chang, Chen-Chun Ou and Julie Y. H. Chan
      Molecular Pharmacology February 2004, 65 (2) 319-325; DOI: https://doi.org/10.1124/mol.65.2.319

  2. Chan, Samuel H. H.

    1. Nitric Oxide Regulates c-fos Expression in Nucleus Tractus Solitarii Induced by Baroreceptor Activation via cGMP-Dependent Protein Kinase and cAMP Response Element-Binding Protein Phosphorylation
      Samuel H. H. Chan, Kui-Fen Chang, Chen-Chun Ou and Julie Y. H. Chan
      Molecular Pharmacology February 2004, 65 (2) 319-325; DOI: https://doi.org/10.1124/mol.65.2.319

  3. Chang, Huai-Ren

    1. Use-Dependent Inhibition of the N-Methyl-D-aspartate Currents by Felbamate: a Gating Modifier with Selective Binding to the Desensitized Channels
      Chung-Chin Kuo, Bei-Jung Lin, Huai-Ren Chang and Chi-Pan Hsieh
      Molecular Pharmacology February 2004, 65 (2) 370-380; DOI: https://doi.org/10.1124/mol.65.2.370

  4. Chang, Kui-Fen

    1. Nitric Oxide Regulates c-fos Expression in Nucleus Tractus Solitarii Induced by Baroreceptor Activation via cGMP-Dependent Protein Kinase and cAMP Response Element-Binding Protein Phosphorylation
      Samuel H. H. Chan, Kui-Fen Chang, Chen-Chun Ou and Julie Y. H. Chan
      Molecular Pharmacology February 2004, 65 (2) 319-325; DOI: https://doi.org/10.1124/mol.65.2.319

  5. Chen, Li

    1. Cytochrome P4501A1 Promotes G1 Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity
      Aviva Levine-Fridman, Li Chen and Cornelis J. Elferink
      Molecular Pharmacology February 2004, 65 (2) 461-469; DOI: https://doi.org/10.1124/mol.65.2.461

  6. Chen, Zili

    1. Design of a High-Affinity Competitive Antagonist of the Vanilloid Receptor Selective for the Calcium Entry-Linked Receptor Population
      Attila Tóth, Peter M. Blumberg, Zili Chen and Alan P. Kozikowski
      Molecular Pharmacology February 2004, 65 (2) 282-291; DOI: https://doi.org/10.1124/mol.65.2.282

  7. Cheng, Hui-fang

    1. The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties
      Bryan N. Becker, Hui-fang Cheng, Timothy G. Hammond and Raymond C. Harris
      Molecular Pharmacology February 2004, 65 (2) 362-369; DOI: https://doi.org/10.1124/mol.65.2.362

  8. Cheng, Yung-chi

    1. Reverse Transcriptase Activity of Hepatitis B Virus (HBV) DNA Polymerase within Core Capsid: Interaction with Deoxynucleoside Triphosphates and Anti-HBV l-Deoxynucleoside Analog Triphosphates
      Wing Lam, Ying Li, Jieh-Yuan Liou, Ginger E. Dutschman and Yung-chi Cheng
      Molecular Pharmacology February 2004, 65 (2) 400-406; DOI: https://doi.org/10.1124/mol.65.2.400

  9. Coon, Charles I.

    1. Peroxisome Proliferator-Activated Receptor-γ-Independent Repression of Collagenase Gene Expression by 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Prostaglandin 15-Deoxy-Δ(12,14) J2: A Role for Smad Signaling
      Kimberlee S. Mix, Charles I. Coon, Evan D. Rosen, Nanjoo Suh, Michael B. Sporn and Constance E. Brinckerhoff
      Molecular Pharmacology February 2004, 65 (2) 309-318; DOI: https://doi.org/10.1124/mol.65.2.309

  10. Corbin, Jackie D.

    1. Properties and Functions of GAF Domains in Cyclic Nucleotide Phosphodiesterases and Other Proteins
      Roya Zoraghi, Jackie D. Corbin and Sharron H. Francis
      Molecular Pharmacology February 2004, 65 (2) 267-278; DOI: https://doi.org/10.1124/mol.65.2.267

  11. Crambert, Gilles

    1. New Molecular Determinants Controlling the Accessibility of Ouabain to Its Binding Site in Human Na,K-ATPase α Isoforms
      Gilles Crambert, Daniele Schaer, Sophie Roy and Käthi Geering
      Molecular Pharmacology February 2004, 65 (2) 335-341; DOI: https://doi.org/10.1124/mol.65.2.335

D

  1. Deitch, Edwin A.

    1. Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells
      Zoltán H. Németh, Hector R. Wong, Kelli Odoms, Edwin A. Deitch, Csaba Szabó, E. Sylvester Vizi and György Haskó
      Molecular Pharmacology February 2004, 65 (2) 342-349; DOI: https://doi.org/10.1124/mol.65.2.342

  2. del Rosso, Angela

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  3. Di Mari, John F.

    1. Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts
      Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega and Don W. Powell
      Molecular Pharmacology February 2004, 65 (2) 470-478; DOI: https://doi.org/10.1124/mol.65.2.470

  4. Distler, Jörg H. W.

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  5. Distler, Oliver

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  6. Dutschman, Ginger E.

    1. Reverse Transcriptase Activity of Hepatitis B Virus (HBV) DNA Polymerase within Core Capsid: Interaction with Deoxynucleoside Triphosphates and Anti-HBV l-Deoxynucleoside Analog Triphosphates
      Wing Lam, Ying Li, Jieh-Yuan Liou, Ginger E. Dutschman and Yung-chi Cheng
      Molecular Pharmacology February 2004, 65 (2) 400-406; DOI: https://doi.org/10.1124/mol.65.2.400

E

  1. Elferink, Cornelis J.

    1. Cytochrome P4501A1 Promotes G1 Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity
      Aviva Levine-Fridman, Li Chen and Cornelis J. Elferink
      Molecular Pharmacology February 2004, 65 (2) 461-469; DOI: https://doi.org/10.1124/mol.65.2.461

  2. Evans, Ronald M.

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

F

  1. Fontana, Jason

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  2. Francis, Sharron H.

    1. Properties and Functions of GAF Domains in Cyclic Nucleotide Phosphodiesterases and Other Proteins
      Roya Zoraghi, Jackie D. Corbin and Sharron H. Francis
      Molecular Pharmacology February 2004, 65 (2) 267-278; DOI: https://doi.org/10.1124/mol.65.2.267

  3. Franks, Nicholas P.

    1. Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
      Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
      Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443

  4. Fujieda, Masaki

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

  5. Fulton, David

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

G

  1. García-Cardeña, Guillermo

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  2. Gay, Renate E.

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  3. Gay, Steffen

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  4. Geering, Käthi

    1. New Molecular Determinants Controlling the Accessibility of Ouabain to Its Binding Site in Human Na,K-ATPase α Isoforms
      Gilles Crambert, Daniele Schaer, Sophie Roy and Käthi Geering
      Molecular Pharmacology February 2004, 65 (2) 335-341; DOI: https://doi.org/10.1124/mol.65.2.335

  5. Geiger, Klaus K.

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

  6. Gratton, Jean-Phillipe

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  7. Gruss, Marco

    1. Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
      Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
      Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443

H

  1. Hagen, Claudia

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  2. Hammond, Timothy G.

    1. The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties
      Bryan N. Becker, Hui-fang Cheng, Timothy G. Hammond and Raymond C. Harris
      Molecular Pharmacology February 2004, 65 (2) 362-369; DOI: https://doi.org/10.1124/mol.65.2.362

  3. Harden, T. Kendall

    1. Agonist Binding and Gq-Stimulating Activities of the Purified Human P2Y1 Receptor
      Gary L. Waldo and T. Kendall Harden
      Molecular Pharmacology February 2004, 65 (2) 426-436; DOI: https://doi.org/10.1124/mol.65.2.426

  4. Harris, Raymond C.

    1. The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties
      Bryan N. Becker, Hui-fang Cheng, Timothy G. Hammond and Raymond C. Harris
      Molecular Pharmacology February 2004, 65 (2) 362-369; DOI: https://doi.org/10.1124/mol.65.2.362

  5. Haskó, György

    1. Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells
      Zoltán H. Németh, Hector R. Wong, Kelli Odoms, Edwin A. Deitch, Csaba Szabó, E. Sylvester Vizi and György Haskó
      Molecular Pharmacology February 2004, 65 (2) 342-349; DOI: https://doi.org/10.1124/mol.65.2.342

  6. Hirth, Astrid

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  7. Hoetzel, Alexander

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

  8. Hsieh, Chi-Pan

    1. Use-Dependent Inhibition of the N-Methyl-D-aspartate Currents by Felbamate: a Gating Modifier with Selective Binding to the Desensitized Channels
      Chung-Chin Kuo, Bei-Jung Lin, Huai-Ren Chang and Chi-Pan Hsieh
      Molecular Pharmacology February 2004, 65 (2) 370-380; DOI: https://doi.org/10.1124/mol.65.2.370

  9. Humar, Matjaz

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

I

  1. Ingelman-Sundberg, Magnus

    1. Different Structural Requirements of the Ligand Binding Domain of the Aryl Hydrocarbon Receptor for High- and Low-Affinity Ligand Binding and Receptor Activation
      Maria Backlund and Magnus Ingelman-Sundberg
      Molecular Pharmacology February 2004, 65 (2) 416-425; DOI: https://doi.org/10.1124/mol.65.2.416

K

  1. Kalden, Joachim R.

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  2. Kamataki, Tetsuya

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

  3. Kiyotani, Kazuma

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

  4. Klaas, Christoph

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

  5. Kozikowski, Alan P.

    1. Design of a High-Affinity Competitive Antagonist of the Vanilloid Receptor Selective for the Calcium Entry-Linked Receptor Population
      Attila Tóth, Peter M. Blumberg, Zili Chen and Alan P. Kozikowski
      Molecular Pharmacology February 2004, 65 (2) 282-291; DOI: https://doi.org/10.1124/mol.65.2.282

  6. Kunitoh, Hideo

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

  7. Kuo, Chung-Chin

    1. Use-Dependent Inhibition of the N-Methyl-D-aspartate Currents by Felbamate: a Gating Modifier with Selective Binding to the Desensitized Channels
      Chung-Chin Kuo, Bei-Jung Lin, Huai-Ren Chang and Chi-Pan Hsieh
      Molecular Pharmacology February 2004, 65 (2) 370-380; DOI: https://doi.org/10.1124/mol.65.2.370

L

  1. Lam, Wing

    1. Reverse Transcriptase Activity of Hepatitis B Virus (HBV) DNA Polymerase within Core Capsid: Interaction with Deoxynucleoside Triphosphates and Anti-HBV l-Deoxynucleoside Analog Triphosphates
      Wing Lam, Ying Li, Jieh-Yuan Liou, Ginger E. Dutschman and Yung-chi Cheng
      Molecular Pharmacology February 2004, 65 (2) 400-406; DOI: https://doi.org/10.1124/mol.65.2.400

  2. Levine-Fridman, Aviva

    1. Cytochrome P4501A1 Promotes G1 Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity
      Aviva Levine-Fridman, Li Chen and Cornelis J. Elferink
      Molecular Pharmacology February 2004, 65 (2) 461-469; DOI: https://doi.org/10.1124/mol.65.2.461

  3. Li, Ying

    1. Reverse Transcriptase Activity of Hepatitis B Virus (HBV) DNA Polymerase within Core Capsid: Interaction with Deoxynucleoside Triphosphates and Anti-HBV l-Deoxynucleoside Analog Triphosphates
      Wing Lam, Ying Li, Jieh-Yuan Liou, Ginger E. Dutschman and Yung-chi Cheng
      Molecular Pharmacology February 2004, 65 (2) 400-406; DOI: https://doi.org/10.1124/mol.65.2.400

  4. Lieb, William R.

    1. Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
      Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
      Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443

  5. Lin, Bei-Jung

    1. Use-Dependent Inhibition of the N-Methyl-D-aspartate Currents by Felbamate: a Gating Modifier with Selective Binding to the Desensitized Channels
      Chung-Chin Kuo, Bei-Jung Lin, Huai-Ren Chang and Chi-Pan Hsieh
      Molecular Pharmacology February 2004, 65 (2) 370-380; DOI: https://doi.org/10.1124/mol.65.2.370

  6. Lin, Michelle I.

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  7. Liou, Jieh-Yuan

    1. Reverse Transcriptase Activity of Hepatitis B Virus (HBV) DNA Polymerase within Core Capsid: Interaction with Deoxynucleoside Triphosphates and Anti-HBV l-Deoxynucleoside Analog Triphosphates
      Wing Lam, Ying Li, Jieh-Yuan Liou, Ginger E. Dutschman and Yung-chi Cheng
      Molecular Pharmacology February 2004, 65 (2) 400-406; DOI: https://doi.org/10.1124/mol.65.2.400

  8. Loop, Torsten

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

  9. Lorenz, Hanns M.

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

M

  1. Mathie, Alistair

    1. Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
      Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
      Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443

  2. Matsumura, Keiko

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

  3. Matucci-Cerinic, Marco

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  4. McCabe, Timothy J.

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  5. McKinnon, Ross A.

    1. Multiple Pharmacophores for the Investigation of Human UDP-Glucuronosyltransferase Isoform Substrate Selectivity
      Michael J. Sorich, John O. Miners, Ross A. McKinnon and Paul A. Smith
      Molecular Pharmacology February 2004, 65 (2) 301-308; DOI: https://doi.org/10.1124/mol.65.2.301

  6. Melliti, K.

    1. Differential Modulation of CaV2.3 Ca2+ Channels by Gαq/11-Coupled Muscarinic Receptors
      R. A. Bannister, K. Melliti and B. A. Adams
      Molecular Pharmacology February 2004, 65 (2) 381-388; DOI: https://doi.org/10.1124/mol.65.2.381

  7. Michel, Beat A.

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  8. Mifflin, Randy C.

    1. Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts
      Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega and Don W. Powell
      Molecular Pharmacology February 2004, 65 (2) 470-478; DOI: https://doi.org/10.1124/mol.65.2.470

  9. Millar, Neil S.

    1. Pharmacological Properties of α9α10 Nicotinic Acetylcholine Receptors Revealed by Heterologous Expression of Subunit Chimeras
      Elizabeth R. Baker, Ruud Zwart, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology February 2004, 65 (2) 453-460; DOI: https://doi.org/10.1124/mol.65.2.453

  10. Miners, John O.

    1. Multiple Pharmacophores for the Investigation of Human UDP-Glucuronosyltransferase Isoform Substrate Selectivity
      Michael J. Sorich, John O. Miners, Ross A. McKinnon and Paul A. Smith
      Molecular Pharmacology February 2004, 65 (2) 301-308; DOI: https://doi.org/10.1124/mol.65.2.301

  11. Mix, Kimberlee S.

    1. Peroxisome Proliferator-Activated Receptor-γ-Independent Repression of Collagenase Gene Expression by 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Prostaglandin 15-Deoxy-Δ(12,14) J2: A Role for Smad Signaling
      Kimberlee S. Mix, Charles I. Coon, Evan D. Rosen, Nanjoo Suh, Michael B. Sporn and Constance E. Brinckerhoff
      Molecular Pharmacology February 2004, 65 (2) 309-318; DOI: https://doi.org/10.1124/mol.65.2.309

  12. Moore, David D.

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

  13. Mu, Ying

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

  14. Müller-Ladner, Ulf

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

N

  1. Nanagara, Ratanavadee

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

  2. Németh, Zoltán H.

    1. Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells
      Zoltán H. Németh, Hector R. Wong, Kelli Odoms, Edwin A. Deitch, Csaba Szabó, E. Sylvester Vizi and György Haskó
      Molecular Pharmacology February 2004, 65 (2) 342-349; DOI: https://doi.org/10.1124/mol.65.2.342

  3. Nishioka, Kusuki

    1. Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
      Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
      Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389

O

  1. Odoms, Kelli

    1. Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells
      Zoltán H. Németh, Hector R. Wong, Kelli Odoms, Edwin A. Deitch, Csaba Szabó, E. Sylvester Vizi and György Haskó
      Molecular Pharmacology February 2004, 65 (2) 342-349; DOI: https://doi.org/10.1124/mol.65.2.342

  2. Ou, Chen-Chun

    1. Nitric Oxide Regulates c-fos Expression in Nucleus Tractus Solitarii Induced by Baroreceptor Activation via cGMP-Dependent Protein Kinase and cAMP Response Element-Binding Protein Phosphorylation
      Samuel H. H. Chan, Kui-Fen Chang, Chen-Chun Ou and Julie Y. H. Chan
      Molecular Pharmacology February 2004, 65 (2) 319-325; DOI: https://doi.org/10.1124/mol.65.2.319

  3. Ozeki, Takeshi

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

P

  1. Pahl, Heike L.

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

  2. Pannen, Benedikt H. J.

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

  3. Papapetropoulos, Andreas

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  4. Pischke, Soeren E.

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

  5. Powell, Don W.

    1. Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts
      Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega and Don W. Powell
      Molecular Pharmacology February 2004, 65 (2) 470-478; DOI: https://doi.org/10.1124/mol.65.2.470

R

  1. Ren, Songrong

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

  2. Rosen, Evan D.

    1. Peroxisome Proliferator-Activated Receptor-γ-Independent Repression of Collagenase Gene Expression by 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Prostaglandin 15-Deoxy-Δ(12,14) J2: A Role for Smad Signaling
      Kimberlee S. Mix, Charles I. Coon, Evan D. Rosen, Nanjoo Suh, Michael B. Sporn and Constance E. Brinckerhoff
      Molecular Pharmacology February 2004, 65 (2) 309-318; DOI: https://doi.org/10.1124/mol.65.2.309

  3. Roy, Sophie

    1. New Molecular Determinants Controlling the Accessibility of Ouabain to Its Binding Site in Human Na,K-ATPase α Isoforms
      Gilles Crambert, Daniele Schaer, Sophie Roy and Käthi Geering
      Molecular Pharmacology February 2004, 65 (2) 335-341; DOI: https://doi.org/10.1124/mol.65.2.335

S

  1. Saada, Jamal I.

    1. Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts
      Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega and Don W. Powell
      Molecular Pharmacology February 2004, 65 (2) 470-478; DOI: https://doi.org/10.1124/mol.65.2.470

  2. Saini, Simrat P. S.

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

  3. Saito, Tetsuya

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

  4. Schaer, Daniele

    1. New Molecular Determinants Controlling the Accessibility of Ouabain to Its Binding Site in Human Na,K-ATPase α Isoforms
      Gilles Crambert, Daniele Schaer, Sophie Roy and Käthi Geering
      Molecular Pharmacology February 2004, 65 (2) 335-341; DOI: https://doi.org/10.1124/mol.65.2.335

  5. Schmidt, Rene

    1. Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
      Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
      Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350

  6. Schuetz, Erin G.

    1. Lessons from the CYP3A4 Promoter
      Erin G. Schuetz
      Molecular Pharmacology February 2004, 65 (2) 279-281; DOI: https://doi.org/10.1124/mol.65.2.279

  7. Sessa, William C.

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  8. Sher, Emanuele

    1. Pharmacological Properties of α9α10 Nicotinic Acetylcholine Receptors Revealed by Heterologous Expression of Subunit Chimeras
      Elizabeth R. Baker, Ruud Zwart, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology February 2004, 65 (2) 453-460; DOI: https://doi.org/10.1124/mol.65.2.453

  9. Smith, Paul A.

    1. Multiple Pharmacophores for the Investigation of Human UDP-Glucuronosyltransferase Isoform Substrate Selectivity
      Michael J. Sorich, John O. Miners, Ross A. McKinnon and Paul A. Smith
      Molecular Pharmacology February 2004, 65 (2) 301-308; DOI: https://doi.org/10.1124/mol.65.2.301

  10. Sonoda, Junichiro

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

  11. Sorich, Michael J.

    1. Multiple Pharmacophores for the Investigation of Human UDP-Glucuronosyltransferase Isoform Substrate Selectivity
      Michael J. Sorich, John O. Miners, Ross A. McKinnon and Paul A. Smith
      Molecular Pharmacology February 2004, 65 (2) 301-308; DOI: https://doi.org/10.1124/mol.65.2.301

  12. Sporn, Michael B.

    1. Peroxisome Proliferator-Activated Receptor-γ-Independent Repression of Collagenase Gene Expression by 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Prostaglandin 15-Deoxy-Δ(12,14) J2: A Role for Smad Signaling
      Kimberlee S. Mix, Charles I. Coon, Evan D. Rosen, Nanjoo Suh, Michael B. Sporn and Constance E. Brinckerhoff
      Molecular Pharmacology February 2004, 65 (2) 309-318; DOI: https://doi.org/10.1124/mol.65.2.309

  13. Suh, Nanjoo

    1. Peroxisome Proliferator-Activated Receptor-γ-Independent Repression of Collagenase Gene Expression by 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Prostaglandin 15-Deoxy-Δ(12,14) J2: A Role for Smad Signaling
      Kimberlee S. Mix, Charles I. Coon, Evan D. Rosen, Nanjoo Suh, Michael B. Sporn and Constance E. Brinckerhoff
      Molecular Pharmacology February 2004, 65 (2) 309-318; DOI: https://doi.org/10.1124/mol.65.2.309

  14. Szabó, Csaba

    1. Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells
      Zoltán H. Németh, Hector R. Wong, Kelli Odoms, Edwin A. Deitch, Csaba Szabó, E. Sylvester Vizi and György Haskó
      Molecular Pharmacology February 2004, 65 (2) 342-349; DOI: https://doi.org/10.1124/mol.65.2.342

T

  1. Takahashi, Yoshiki

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

  2. Toma, David

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

  3. Tóth, Attila

    1. Design of a High-Affinity Competitive Antagonist of the Vanilloid Receptor Selective for the Calcium Entry-Linked Receptor Population
      Attila Tóth, Peter M. Blumberg, Zili Chen and Alan P. Kozikowski
      Molecular Pharmacology February 2004, 65 (2) 282-291; DOI: https://doi.org/10.1124/mol.65.2.282

U

  1. Uppal, Hirdesh

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

V

  1. Valentich, John D.

    1. Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts
      Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega and Don W. Powell
      Molecular Pharmacology February 2004, 65 (2) 470-478; DOI: https://doi.org/10.1124/mol.65.2.470

  2. Vizi, E. Sylvester

    1. Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells
      Zoltán H. Németh, Hector R. Wong, Kelli Odoms, Edwin A. Deitch, Csaba Szabó, E. Sylvester Vizi and György Haskó
      Molecular Pharmacology February 2004, 65 (2) 342-349; DOI: https://doi.org/10.1124/mol.65.2.342

W

  1. Waldo, Gary L.

    1. Agonist Binding and Gq-Stimulating Activities of the Purified Human P2Y1 Receptor
      Gary L. Waldo and T. Kendall Harden
      Molecular Pharmacology February 2004, 65 (2) 426-436; DOI: https://doi.org/10.1124/mol.65.2.426

  2. Wellstein, Anton

    1. Systemic Morphine Administration Suppresses Genes Involved in Antigen Presentation
      Karen Beagles, Anton Wellstein and Barbara Bayer
      Molecular Pharmacology February 2004, 65 (2) 437-442; DOI: https://doi.org/10.1124/mol.65.2.437

  3. Wong, Hector R.

    1. Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells
      Zoltán H. Németh, Hector R. Wong, Kelli Odoms, Edwin A. Deitch, Csaba Szabó, E. Sylvester Vizi and György Haskó
      Molecular Pharmacology February 2004, 65 (2) 342-349; DOI: https://doi.org/10.1124/mol.65.2.342

X

  1. Xie, Wen

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

  2. Xu, Li

    1. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
      Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
      Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292

Y

  1. Yamazaki, Hiroshi

    1. Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
      Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
      Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326

Z

  1. Zhou, Zongmin

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  2. Zoellner, Stefan

    1. Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
      Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
      Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407

  3. Zoraghi, Roya

    1. Properties and Functions of GAF Domains in Cyclic Nucleotide Phosphodiesterases and Other Proteins
      Roya Zoraghi, Jackie D. Corbin and Sharron H. Francis
      Molecular Pharmacology February 2004, 65 (2) 267-278; DOI: https://doi.org/10.1124/mol.65.2.267

  4. Zwart, Ruud

    1. Pharmacological Properties of α9α10 Nicotinic Acetylcholine Receptors Revealed by Heterologous Expression of Subunit Chimeras
      Elizabeth R. Baker, Ruud Zwart, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology February 2004, 65 (2) 453-460; DOI: https://doi.org/10.1124/mol.65.2.453
Back to top

In this issue

Advertisement